Pathogenesis of Cholinergic Urticaria in Relation to Sweating

被引:36
作者
Bito, Toshinori [1 ]
Sawada, Yu [2 ]
Tokura, Yoshiki [3 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Univ Occupat & Environm Hlth, Dept Dermatol, Fukuoka, Japan
[3] Hamamatsu Univ Sch Med, Dept Dermatol, Shizuoka, Japan
关键词
acetylcholine; acetylcholine receptor; anhidrosis; hypohidrosis; sweat hypersensitivity; RAT MAST-CELLS; HISTAMINE-RELEASE; ATOPIC-DERMATITIS; AUTOLOGOUS SWEAT; HYPERSENSITIVITY; ANHIDROSIS; ANTIGEN; SKIN; AUTOANTIBODIES; ACETYLCHOLINE;
D O I
10.2332/allergolint.12-RAI-0485
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Cholinergic urticaria (CU) has clinically characteristic features, and has been frequently described in the literature. However, despite its comparatively old history, the pathogenesis and classification remains to be clarified. CU patients are occasionally complicated by anhidrosis and/or hypohidrosis. This reduced-sweat type should be included in the classification because the therapeutic approaches are different from the ordinary CU. It is also well-known that autologous sweat is involved in the occurrence of CU. More than half of CU patients may have sweat hypersensitivity. We attempt to classify CU and address the underlying mechanisms of CU based on the published data and our findings. The first step for classification of CU seems to discriminate the presence or absence of hypersensitivity to autologous sweat. The second step is proposed to determine whether the patients can sweat normally or not. With these data, the patients could be categorized into three subtypes: (1) CU with sweat hypersensitivity; (2) CU with acquired anhidrosis and/or hypohidrosis; (3) idiopathic CU. The pathogenesis of each subtype is also discussed in this review.
引用
收藏
页码:539 / 544
页数:6
相关论文
共 58 条
  • [51] Assessment of autoimmunity in patients with chronic urticaria
    Tong, LJ
    Balakrishnan, G
    Kochan, JP
    Kinet, JP
    Kaplan, AP
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (04) : 461 - 465
  • [52] Toshina Y, 2002, PRACT DERMATOL, V24, P743
  • [53] Tsuchiya T, 2004, JPN J CLIN DERMATOL, V58, P129
  • [54] Tsuchiyama M, 2003, J HYOGO MED ASS, V45, P160
  • [55] Cholinergic urticaria successfully treated with scopolamine butylbromide
    Tsunemi, Y
    Ihn, H
    Saeki, H
    Tamaki, K
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2003, 42 (10) : 850 - 850
  • [56] Further characterization of muscarinic agonist-induced epileptiform bursting activity in immature rat piriform cortex, in vitro
    Whalley, BJ
    Postlethwaite, M
    Constanti, A
    [J]. NEUROSCIENCE, 2005, 134 (02) : 549 - 566
  • [57] BENEFICIAL-EFFECTS OF DANAZOL ON SYMPTOMS AND LABORATORY CHANGES IN CHOLINERGIC URTICARIA
    WONG, E
    EFTEKHARI, N
    GREAVES, MW
    WARD, AM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1987, 116 (04) : 553 - 556
  • [58] Yoshida M, 2009, PRACTICAL DERMATOL, V31, P41